Enhancing Capital
TMO icon

Enhancing Capital’s Thermo Fisher Scientific TMO Stock Holding History

Enhancing Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$438K Hold
649
– – 0.3% 59
2026
Q2 		$325K Buy
649
+143
+28% +$68.6K 0.22% 76
2026
Q1 		$249K Hold
506
– – 0.18% 78
2025
Q4 		$293K Sell
506
-16
-3% -$9.05K 0.21% 78
2025
Q3 		$253K Buy
+522
New +$243K 0.19% 77
2025
Q2 		– Sell
-412
Closed -$205K – 94
2025
Q1 		$205K Buy
+412
New +$223K 0.16% 91

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $19.7B AUM 7.08% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Loring Wolcott & Coolidge Fiduciary Advisors
Loring Wolcott & Coolidge Fiduciary Advisors Boston, Massachusetts $10.8B AUM 9.05% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Enhancing Capital's TMO Position: Q3 2026 in Review

Enhancing Capital held its Thermo Fisher Scientific (TMO) position steady in Q3 2026 at 649 shares worth $438K. The position accounts for 0.3% of the portfolio, ranked #59.

Enhancing Capital first reported a position in TMO in Q1 2025 and has held it in 6 quarters since. 1,103 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Enhancing Capital held 649 shares of Thermo Fisher Scientific worth $438K as of Q3 2026.
  • Enhancing Capital left its Thermo Fisher Scientific share count unchanged in Q3 2026.
  • Thermo Fisher Scientific made up 0.3% of Enhancing Capital's portfolio in Q3 2026, its #59 holding.
  • Enhancing Capital first reported a position in Thermo Fisher Scientific in Q1 2025 and has held it in 6 quarters since.
  • 1,103 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Enhancing Capital's 13F filing for Q3 2026, filed 26 Oct 2026.